(XSX7) Stoxx Europe 600 1D - Overview
Etf: Stocks, Europe, Large-Cap, Diversified
Dividends
| Dividend Yield | 2.83% |
| Yield on Cost 5y | 3.95% |
| Yield CAGR 5y | 21.05% |
| Payout Consistency | 97.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 11.2% |
| Relative Tail Risk | 5.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 11.51 |
| Character TTM | |
|---|---|
| Beta | 0.149 |
| Beta Downside | 0.290 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.32% |
| CAGR/Max DD | 0.98 |
Description: XSX7 Stoxx Europe 600 1D January 25, 2026
XSX7 is the Xtrackers Stoxx Europe 600 UCITS ETF, domiciled in Germany and listed on XETRA. It tracks the Morningstar DM Eur TME NR EUR index, offering exposure to roughly 600 large-cap European equities across 16 countries, with a sector tilt toward financials (≈22 % weight) and industrials (≈18 %). The fund’s TER is 0.15 % and it holds €3.8 bn in assets under management (AUM) as of January 2026, with an average tracking error of 0.07 % over the past 12 months.
Recent macro-drivers shaping the ETF’s performance include the European Central Bank’s policy stance-still in a tightening cycle with the deposit facility at 4.25 %-and a modest rebound in euro-zone corporate earnings (+4.2 % YoY Q4 2025). The index’s dividend yield sits at 3.1 % (annualized, trailing-12-month), reflecting the high weight in dividend-paying banks and utilities. Compared with its peer group, XSX7 has outperformed the MSCI Europe Large-Cap index by 120 bps over the past year, driven largely by a 7 % gain in the financial sector amid improving net interest margins.
For a deeper, data-rich comparison of XSX7’s risk-adjusted returns and sector sensitivities, consider exploring the analytics on ValueRay.
What is the price of XSX7 shares?
Over the past week, the price has changed by +0.89%, over one month by +1.99%, over three months by +9.04% and over the past year by +16.71%.
Is XSX7 a buy, sell or hold?
What are the forecasts/targets for the XSX7 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 108.3 | 13.3% |
XSX7 Fundamental Data Overview February 04, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 950.3m EUR (950.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 950.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 950.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.46% (E(950.3m)/V(950.3m) * Re(6.46%) + (debt-free company))
Discount Rate = 6.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)